Literature DB >> 28027479

Characterization of founder viruses in very early SIV rectal transmission.

Zhe Yuan1, Fangrui Ma1, Andrew J Demers1, Dong Wang2, Jianqing Xu3, Mark G Lewis4, Qingsheng Li5.   

Abstract

A better understanding of HIV-1 transmission is critical for developing preventative strategies. To that end, we analyzed 524 full-length env sequences of SIVmac251 at 6 and 10 days post intrarectal infection of rhesus macaques. There was no tissue compartmentalization of founder viruses across plasma, rectal and distal lymphatic tissues for most animals; however one animal has evidence of virus tissue compartmentalization. Despite identical viral inoculums, founder viruses were animal-specific, primarily derived from rare variants in the inoculum, and have a founder virus signature that can distinguish dominant founder variants from minor founder or untransmitted variants in the inoculum. Importantly, the sequences of post-transmission defective viruses were phylogenetically associated with competent viral variants in the inoculum and were mainly converted from competent viral variants by frameshift rather than APOBEC mediated mutations, suggesting the converting the transmitted viruses into defective viruses through frameshift mutation is an important component of rectal transmission bottleneck. SIGNIFICANCE: Anorectal receptive intercourse is a common route of HIV-1 transmission and a better understanding of the transmission mechanisms is critical for developing HIV-1 preventative strategies. Here, we report that there is no tissue compartmentalization of founder viruses during very early rectal transmission of SIV in the majority of rhesus macaques and founder viruses are preferentially derived from rare variant in the inoculum. We also found that founder viruses are animal-specific despite identical viral inoculums. After viruses cross the mucosal barriers, the host further reduces viral diversity by converting some of the transmitted functional viruses into defective viruses through frameshift rather than APOBEC derived mutations. To our knowledge, this is the first study of founder viruses at multiple tissue sites during very early rectal transmission.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Defective variants; Founder virus signature; Genetic bottleneck; Rectal transmission; Tissue compartmentalization; Very early virological events

Mesh:

Year:  2016        PMID: 28027479      PMCID: PMC5276734          DOI: 10.1016/j.virol.2016.12.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Clustering of highly homologous sequences to reduce the size of large protein databases.

Authors:  W Li; L Jaroszewski; A Godzik
Journal:  Bioinformatics       Date:  2001-03       Impact factor: 6.937

2.  Role of donor genital tract HIV-1 diversity in the transmission bottleneck.

Authors:  Debrah I Boeras; Peter T Hraber; Mackenzie Hurlston; Tammy Evans-Strickfaden; Tanmoy Bhattacharya; Elena E Giorgi; Joseph Mulenga; Etienne Karita; Bette T Korber; Susan Allen; Clyde E Hart; Cynthia A Derdeyn; Eric Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Viral characteristics of transmitted HIV.

Authors:  Cynthia A Derdeyn; Eric Hunter
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

4.  SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma.

Authors:  Zhong-Min Ma; Brandon F Keele; Huma Qureshi; Mars Stone; Veronique Desilva; Linda Fritts; Jeffrey D Lifson; Christopher J Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2011-07-06       Impact factor: 2.205

5.  Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

Authors:  Jinyan Liu; Brandon F Keele; Hui Li; Sheila Keating; Philip J Norris; Angela Carville; Keith G Mansfield; Georgia D Tomaras; Barton F Haynes; Dror Kolodkin-Gal; Norman L Letvin; Beatrice H Hahn; George M Shaw; Dan H Barouch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 6.  Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.

Authors:  Sarah B Joseph; Ronald Swanstrom; Angela D M Kashuba; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2015-06-08       Impact factor: 60.633

7.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

8.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

9.  Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Authors:  Richard E Haaland; Paulina A Hawkins; Jesus Salazar-Gonzalez; Amber Johnson; Amanda Tichacek; Etienne Karita; Olivier Manigart; Joseph Mulenga; Brandon F Keele; George M Shaw; Beatrice H Hahn; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

10.  Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.

Authors:  Charles T T Edwards; Edward C Holmes; Daniel J Wilson; Raphael P Viscidi; Elaine J Abrams; Rodney E Phillips; Alexei J Drummond
Journal:  BMC Evol Biol       Date:  2006-03-23       Impact factor: 3.260

View more
  4 in total

1.  Role of Tunneling Nanotube-like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread.

Authors:  George Okafo; Silvana Valdebenito; Maribel Donoso; Ross Luu; David Ajasin; Brendan Prideaux; Santhi Gorantla; Eliseo A Eugenin
Journal:  J Immunol       Date:  2020-10-09       Impact factor: 5.422

2.  Identification of Unequally Represented Founder Viruses Among Tissues in Very Early SIV Rectal Transmission.

Authors:  Jian Chen; Yanqin Ren; Lance Daharsh; Lu Liu; Guobin Kang; Qingsheng Li; Qiang Wei; Yanmin Wan; Jianqing Xu
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

3.  Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection.

Authors:  Sodsai Tovanabutra; Rujipas Sirijatuphat; Phuc T Pham; Lydia Bonar; Elizabeth A Harbolick; Meera Bose; Hongshuo Song; David Chang; Celina Oropeza; Anne Marie O'Sullivan; Joyce Balinang; Eugene Kroon; Donn J Colby; Carlo Sacdalan; Joanna Hellmuth; Phillip Chan; Peeriya Prueksakaew; Suteeraporn Pinyakorn; Linda L Jagodzinski; Duanghathai Sutthichom; Suwanna Pattamaswin; Mark de Souza; Robert A Gramzinski; Jerome H Kim; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich; Victor Valcour; Gustavo H Kijak; Eric Sanders-Buell; Serena Spudich
Journal:  Cells       Date:  2019-08-15       Impact factor: 6.600

Review 4.  A 30-year journey of trial and error towards a tolerogenic AIDS vaccine.

Authors:  Jean-Marie Andrieu; Wei Lu
Journal:  Arch Virol       Date:  2018-07-24       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.